Bioadaptives, Inc. SEC filings BDPT
Bioadaptives, Inc. has 176 filings in SEC EDGAR's recent list, going back to May 3, 2013. Its latest annual report, Form 10-K, was filed on Apr 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 4, 2026 | Nov 2, 2026 |
| 4 | Insider transaction | Oct 6, 2026 | Oct 1, 2026 |
| 4 | Insider transaction | Sep 3, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Aug 4, 2026 | Aug 1, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | May 5, 2026 | May 1, 2026 |
| 4 | Insider transaction | Apr 3, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Feb 1, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Dec 3, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Nov 4, 2025 | Nov 1, 2025 |
| 4 | Insider transaction | Oct 6, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Sep 3, 2025 | Sep 1, 2025 |
| 4 | Insider transaction | Aug 5, 2025 | Aug 1, 2025 |
| 4 | Insider transaction | Jul 3, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | Jun 1, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 1, 2025 |
| 4 | Insider transaction | May 5, 2025 | Feb 15, 2025 |
| 3 | Initial insider ownership | May 5, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Dec 3, 2024 | Nov 22, 2024 |
| SC 13D | Ownership over 5% (active) | Oct 22, 2024 | — |
| SC 13D | Ownership over 5% (active) | Oct 22, 2024 | — |
| 3 | Initial insider ownership | Jan 5, 2016 | May 3, 2013 |
| SC 13D/A | Amended ownership over 5% (active) | Jan 5, 2016 | — |
| SC 13D | Ownership over 5% (active) | Jan 5, 2016 | — |
| 4 | Insider transaction | Jan 17, 2014 | Oct 1, 2013 |
| 4 | Insider transaction | Jan 17, 2014 | Oct 1, 2013 |
| 3 | Initial insider ownership | Aug 13, 2013 | Jun 21, 2013 |
| 3 | Initial insider ownership | Aug 13, 2013 | Jun 21, 2013 |
| 3 | Initial insider ownership | Jul 23, 2013 | Jun 21, 2013 |
| 4 | Insider transaction | Jul 3, 2013 | Jun 21, 2013 |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BDPT (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Las Vegas, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1575142
- Former names
- APEX 8 Inc. (until Aug 19, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.